Nasus Pharma Ltd. (NSRX) — Financial Flexibility Index
Nasus Pharma Ltd. (NSRX) has a Financial Flexibility Index of -2.19x as of December 2025. Free cash flow of $-4.90 Million (operating CF $-4.92 Million minus capex $14.00K) represents -2% of total liabilities ($2.24 Million). Check NSRX asset liquidity ratio to evaluate the company's liquid asset resilience ratio.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Nasus Pharma Ltd. Financial Flexibility Index (2022–2025)
Historical Financial Flexibility Index trend for Nasus Pharma Ltd. across 4 annual periods. See Nasus Pharma Ltd. working capital to net assets to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Nasus Pharma Ltd. (2022–2025)
Year-by-year free cash flow to debt coverage for Nasus Pharma Ltd.. For the full company profile including market capitalisation, see market cap of Nasus Pharma Ltd..
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -2.19x | $-4.90 Million | $-4.92 Million | $2.24 Million | ▼ -1195.8% |
| 2024 | -0.17x | $-665.00K | $-665.00K | $3.93 Million | ▲ +30.2% |
| 2023 | -0.24x | $-1.03 Million | $-1.03 Million | $4.24 Million | ▲ +35.8% |
| 2022 | -0.38x | $-1.21 Million | $-1.21 Million | $3.20 Million | — |